Literature DB >> 9745437

Promoter characterization of the human Na+/I- symporter.

K Y Ryu1, Q Tong, S M Jhiang.   

Abstract

The Na+/I- symporter (NIS) is the plasma membrane protein that mediates active iodide uptake into thyroid follicular cells. To understand the molecular mechanisms of human NIS (hNIS) gene regulation, the 2-kb immediate 5'-flanking region of hNIS was characterized. The tentative hNIS transcriptional start site was mapped to -375 nucleotide relative to the ATG site. Various 5'-genomic DNA fragments were tested for promoter activity in thyroid and nonthyroid cells. Our results indicate that the DNA regulatory elements in the 2-kb immediate 5'-flanking region were not sufficient to confer thyroid-selective transcription of the hNIS gene. In addition, hNIS minimal promoter was localized to a region of 144 bp that contains a 90-bp stretch of a highly conserved DNA fragment between hNIS and rat NIS.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9745437     DOI: 10.1210/jcem.83.9.5118

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  10 in total

Review 1.  Regulation of sodium/iodide symporter.

Authors:  S M Jhiang
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

Review 2.  The biology of the sodium iodide symporter and its potential for targeted gene delivery.

Authors:  Mohan Hingorani; Christine Spitzweg; Georges Vassaux; Kate Newbold; Alan Melcher; Hardev Pandha; Richard Vile; Kevin Harrington
Journal:  Curr Cancer Drug Targets       Date:  2010-03       Impact factor: 3.428

3.  Identification of cyclic adenosine 3',5'-monophosphate response element modulator as an activator of the human sodium/iodide symporter upstream enhancer.

Authors:  Mike S Fenton; Kenneth M Marion; Jerome M Hershman
Journal:  Endocrinology       Date:  2008-01-17       Impact factor: 4.736

4.  Transcription factor Nkx-2.5 induces sodium/iodide symporter gene expression and participates in retinoic acid- and lactation-induced transcription in mammary cells.

Authors:  Monica Dentice; Cristina Luongo; Antonia Elefante; Romina Romino; Raffaele Ambrosio; Mario Vitale; Guido Rossi; Gianfranco Fenzi; Domenico Salvatore
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

5.  Retinoic acid in patients with radioiodine non-responsive thyroid carcinoma.

Authors:  S Mendes Coelho; R Corbo; A Buescu; D P Carvalho; M Vaisman
Journal:  J Endocrinol Invest       Date:  2004-04       Impact factor: 4.256

6.  The sodium/iodide symporter NIS is a transcriptional target of the p53-family members in liver cancer cells.

Authors:  F Guerrieri; S Piconese; C Lacoste; V Schinzari; B Testoni; Y Valogne; S Gerbal-Chaloin; D Samuel; C Bréchot; J Faivre; M Levrero
Journal:  Cell Death Dis       Date:  2013-09-19       Impact factor: 8.469

7.  HEX expression and localization in normal mammary gland and breast carcinoma.

Authors:  Cinzia Puppin; Fabio Puglisi; Lucia Pellizzari; Guidalberto Manfioletti; Marta Pestrin; Maura Pandolfi; Andrea Piga; Carla Di Loreto; Giuseppe Damante
Journal:  BMC Cancer       Date:  2006-07-19       Impact factor: 4.430

8.  Increased expression of AP2 and Sp1 transcription factors in human thyroid tumors: a role in NIS expression regulation?

Authors:  Eusebio Chiefari; Antonio Brunetti; Franco Arturi; Jean-Michel Bidart; Diego Russo; Martin Schlumberger; Sebastiano Filetti
Journal:  BMC Cancer       Date:  2002-12-10       Impact factor: 4.430

9.  The Thyroid Na+/I- Symporter: Molecular Characterization and Genomic Regulation.

Authors:  Hani Alotaibi; Merve Tuzlakoğlu-Öztürk; Uygar Halis Tazebay
Journal:  Mol Imaging Radionucl Ther       Date:  2017-02-09

10.  Histone deacetylation of NIS promoter underlies BRAF V600E-promoted NIS silencing in thyroid cancer.

Authors:  Zongjing Zhang; Dingxie Liu; Avaniyapuram Kannan Murugan; Zhimin Liu; Mingzhao Xing
Journal:  Endocr Relat Cancer       Date:  2014-01-30       Impact factor: 5.678

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.